Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Jellagen Pty Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10376
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds, which can be used for cell culture. Jellagen also carries out research and development of type II collagen for bone diseases. The company has collaborations with universities for Nano Health for applying their electrospinning technology to electrospin the collagen into nanofibers used in medical devices. It caters to medical devices, regenerative medicine and in vitro diagnostic markets. Jellagen is headquartered in Cardiff, the UK.

Jellagen Pty Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Jellagen Pty Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Jellagen Raises USD2.2 Million Financing 10
Jellagen Raises USD0.93 Million in Venture Financing 11
Jellagen Raises USD0.66 Million in Venture Financing 12
Private Equity 13
Jellagen Raises USD5.3 Million in Financing 13
Partnerships 14
Collagen Solutions Enters into Research Agreement with Jellagen 14
Jellagen Pty Ltd – Key Competitors 15
Jellagen Pty Ltd – Key Employees 16
Jellagen Pty Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Jellagen Pty Ltd, Medical Equipment, Key Facts 2
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Deals By Market, 2012 to YTD 2018 8
Jellagen Pty Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Jellagen Raises USD2.2 Million Financing 10
Jellagen Raises USD0.93 Million in Venture Financing 11
Jellagen Raises USD0.66 Million in Venture Financing 12
Jellagen Raises USD5.3 Million in Financing 13
Collagen Solutions Enters into Research Agreement with Jellagen 14
Jellagen Pty Ltd, Key Competitors 15
Jellagen Pty Ltd, Key Employees 16

List of Figures
Jellagen Pty Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Jellagen Pty Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Jellagen Pty Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Jellagen Pty Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Jellagen Pty Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Gas & Industrial Co (2080):企業の財務・戦略的SWOT分析
    National Gas & Industrial Co (2080) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pacific Ethanol Inc (PEIX):企業の財務・戦略的SWOT分析
    Pacific Ethanol Inc (PEIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • JSS Medical Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JSS Medical Research Inc (JSS Medical Research) is a contract research organization that offers clinical research services. The organization provides clinical trial services in therapeutic areas such as oncology, infectious disease, cardiovascular disorders, psychiatry, neurology, respirator …
  • Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析
    Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • KSK Power Ventur plc (KSK):企業の財務・戦略的SWOT分析
    Summary KSK Power Ventur plc (KSK Power) is a power generation company that operates in development, operation, construction, and maintenance of power plants. The company operates through four business segments such as power generation, mineral resources, renewable and asset management, among others …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tivoli A/S:企業の戦略・SWOT・財務分析
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Meritage Homes Corporation:企業の戦略・SWOT・財務情報
    Meritage Homes Corporation - Strategy, SWOT and Corporate Finance Report Summary Meritage Homes Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hill’s Pet Nutrition, Inc.:企業の戦略的SWOT分析
    Hill's Pet Nutrition, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Daiwa Securities Group Inc:戦略・SWOT・企業財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kyivstar JSC:企業の戦略的SWOT分析
    Kyivstar JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Voith GmbH & Co KGaA:企業の戦略的SWOT分析
    Voith GmbH & Co KGaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Rhon-Klinikum AG (RHK):企業の財務・戦略的SWOT分析
    Summary Rhon-Klinikum AG (Rhon-Klinikum) is a healthcare service provider that offers medical care services. The center offers services such as nursing, physiotherapy, ergotherapy, logopaedics and dietician services. It provides medical assistance professions in the areas of functional diagnosis, la …
  • Oxford Immunotec Ltd-医療機器分野:企業M&A・提携分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) is a medical device company that develops and commercializes proprietary tests. The company provides international T cell measurement products including T-Cell Xtend and T-SPOT. Its T-SPOT.TB test diagnoses both latent TB infection and active disease b …
  • Indiana Resources Limited:企業の戦略・SWOT・財務分析
    Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆